Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insomnia01:27

Insomnia

284
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
284
Management of Insomnia01:19

Management of Insomnia

418
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
418
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

751
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
751
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

304
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
304
Blind Procedures02:07

Blind Procedures

12.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline five-times sit-to-stand and functional reach were associated with falls in adults aged 50 years and older in Saudi Arabia: a nine-month prospective cohort study.

Irish journal of medical science·2026
Same author

Mental Health, Sleep, and Physical Activity Among Young Saudi Women During Ramadan: A Comparative Cohort Study.

Nature and science of sleep·2026
Same author

Optimizing rare neurological disease trials: Bayesian frameworks and hierarchical models for improved efficiency in clinical trial design.

Journal of biopharmaceutical statistics·2026
Same author

Factors Influencing Attendance to Physical Therapy Services Among Children with Cerebral Palsy in Saudi Arabia.

Patient preference and adherence·2026
Same author

Exploring EMG Biofeedback in Core Training - Bosu Ball vs Swiss Ball Efficacy for Collegiate Students with Mechanical Low Back Pain: A Randomized Controlled Trial.

Journal of multidisciplinary healthcare·2026
Same author

Prevalence and Association of Neuropathic Pain and Central Sensitization in Participants with Knee Osteoarthritis: Establishing a Cutoff Score for the Central Sensitization Inventory.

Journal of pain research·2026

Related Experiment Video

Updated: Dec 3, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K

Using Cognitive Behavioral Therapy for Insomnia in People with Type 2 Diabetes, Pilot RCT Part I: Sleep and

Mohammed M Alshehri1,2, Aqeel M Alenazi3, Shaima A Alothman4

  • 1Physical Therapy and Rehabilitation Science Department, University of Kansas Medical Center, Kansas City, Kansas.

Behavioral Sleep Medicine
|October 28, 2020
PubMed
Summary

Cognitive Behavioral Therapy for Insomnia (CBT-I) significantly improved insomnia symptoms, sleep quality, and reduced depression and anxiety in Type 2 diabetes patients compared to health education. CBT-I offers a clinically meaningful benefit for sleep and related symptoms in this population.

More Related Videos

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.3K
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.4K

Related Experiment Videos

Last Updated: Dec 3, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.3K
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.4K

Area of Science:

  • Sleep Medicine
  • Endocrinology
  • Behavioral Therapy

Background:

  • Insomnia is a common issue in Type 2 diabetes (T2D).
  • Poor sleep can exacerbate T2D complications.
  • Cognitive Behavioral Therapy for Insomnia (CBT-I) is a potential intervention.

Purpose of the Study:

  • To evaluate the efficacy of CBT-I versus health education (HE) on insomnia severity in T2D patients.
  • To explore CBT-I's impact on other sleep parameters and associated symptoms.

Main Methods:

  • Randomized controlled trial with 28 T2D participants.
  • Intervention groups: CBT-I (n=14) and HE (n=14).
  • Sleep outcomes and symptoms assessed using validated measures, actigraphy, and sleep diaries.

Main Results:

  • CBT-I group showed significant improvements in insomnia symptoms, sleep quality, and self-efficacy compared to HE.
  • Objective and subjective measures indicated enhanced sleep latency and efficiency with CBT-I.
  • CBT-I also led to greater reductions in depression and anxiety symptoms.

Conclusions:

  • CBT-I demonstrates a clinically significant positive effect on sleep and related symptoms in individuals with T2D and insomnia.
  • Further research is warranted to understand the long-term impact of CBT-I in this demographic.